Abstract
Metastatic melanoma is considered to be one of the most aggressive skin tumors and of poor prognosis for patients. It is also recognized as a heterogeneous disease and with a highly complex etiology, considering the profile of gene mutations. Understanding these molecular changes has a major role in the development of new drugs that act specifically on mutations related to tumor type. Acc…